HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Possible involvement of endothelin-1 in cardioprotective effects of benidipine.

Abstract
Benidipine hydrochloride has been developed as an antagonist for the L-type calcium channel and is used as an anti-hypertensive drug. But recent studies have reported that benidipine exerts not only antihypertensive actions but also anti-hypertrophic actions on cardiac muscles. Endothelin-1 (ET-1), one of the endogenous pathological humoral factors of cardiovascular diseases such as hypertension and heart failure, has a strong vasoconstrictive action and could induce hypertension and cardiac hypertrophy. So, it is a matter of great interest whether or not calcium antagonists can decrease cardiac hypertrophy induced by the pathological vasoactive substances such as ET-1. Thus, the present study was designed to elucidate the effects of benidipine on cardiac hypertrophy, and particularly on the interaction with ET-1, using neonatal rat cardiac myocytes (MCs) and cardiac non-myocytes (NMCs) culture systems. Cells were cultured with or without ET-1, benidipine, and nifedipine and the effects of calcium antagonists on cardiac hypertrophy were evaluated by incorporations of [3H]-leucine and [3H]-thymidine into MCs and/or NMCs. Benidipine significantly decreased the ET-1-induced increase of [3H]-leucine and [3H]-thymidine uptake into cardiac MCs and NMCs, whereas no significant effects of nifedipine were observed. Furthermore, benidipine (10(-8)M) attenuated ET-1 secretions from NMCs. In summary, benidipine at least partially decreased the cardiac hypertrophy induced by paracrine mechanisms through its attenuation of ET-1 secretions from NMCs. Benidipine could thus be a useful tool for preventing cardiac hypertrophy due to hypertension.
AuthorsK Ikeda, K Tojo, G Tokudome, T Akashi, T Hosoya, M Harada, O Nakagawa, K Nakao
JournalHypertension research : official journal of the Japanese Society of Hypertension (Hypertens Res) Vol. 23 Issue 5 Pg. 491-6 (Sep 2000) ISSN: 0916-9636 [Print] England
PMID11016804 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Calcium Channel Blockers
  • Dihydropyridines
  • Endothelin-1
  • Tritium
  • benidipine
  • Leucine
  • Nifedipine
  • Thymidine
Topics
  • Animals
  • Animals, Newborn
  • Calcium Channel Blockers (pharmacology)
  • Cardiomegaly (drug therapy)
  • Cells, Cultured
  • Dihydropyridines (pharmacology)
  • Endothelin-1 (pharmacology)
  • Hypertension (drug therapy)
  • Leucine (pharmacokinetics)
  • Muscle Fibers, Skeletal (cytology, drug effects, metabolism)
  • Myocardium (cytology)
  • Nifedipine (pharmacology)
  • Rats
  • Rats, Wistar
  • Thymidine (pharmacokinetics)
  • Tritium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: